U.S. FDA Pilot Program Will Speed U.S. Entry Of Drugs With Secure Supply Chains
This article was originally published in PharmAsia News
FDA is developing an implementation plan for pilot testing a program to speed entry into the U.S. of drugs that flow through a strong supply chain
You may also be interested in...
Limited roll out of the PREDICT system shows it has been effective in identifying the riskier imports that should be the focus of inspectors' attention, Commissioner Hamburg tells House panel
Agency wants to target supply-chain threats and help judge the value of information received from third-party inspections.